Providence Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
11,128
+199
+2% +$23K 0.86% 40
2025
Q4
$1.16M Sell
10,929
-200
-2% -$18.8K 0.73% 44
2025
Q3
$969K Buy
11,129
+215
+2% +$17.7K 0.61% 46
2025
Q2
$875K Sell
10,914
-81
-0.7% -$6.44K 0.6% 48
2025
Q1
$956K Buy
10,995
+617
+6% +$57.6K 0.72% 45
2024
Q4
$1.04M Sell
10,378
-66
-0.6% -$6.8K 0.78% 44
2024
Q3
$1.11M Buy
10,444
+290
+3% +$34.5K 0.82% 41
2024
Q2
$1.31M Buy
10,154
+280
+3% +$36.1K 1.04% 32
2024
Q1
$1.29M Buy
9,874
+302
+3% +$37.2K 1.1% 31
2023
Q4
$1.22M Buy
9,572
+511
+6% +$53K 1.1% 28
2023
Q3
$924K Buy
9,061
+175
+2% +$18.9K 1.03% 32
2023
Q2
$1.01M Sell
8,886
-825
-8% -$93.7K 1.12% 30
2023
Q1
$1.11M Buy
9,711
+96
+1% +$10.4K 0.82% 41
2022
Q4
$1.09M Buy
9,615
+125
+1% +$12.8K 0.81% 40
2022
Q3
$976K Sell
9,490
-173
-2% -$15.4K 0.73% 44
2022
Q2
$901K Buy
9,663
+923
+11% +$81.8K 0.65% 49
2022
Q1
$730K Buy
8,740
+215
+3% +$17K 0.47% 62
2021
Q4
$685K Hold
8,525
0.43% 67
2021
Q3
$703K Buy
8,525
+300
+4% +$22.8K 0.49% 59
2021
Q2
$643K Buy
8,225
+66
+0.8% +$4.91K 0.44% 62
2021
Q1
$600K Buy
8,159
+1,268
+18% +$93.5K 0.44% 63
2020
Q4
$530K Buy
6,891
+809
+13% +$61.9K 0.44% 62
2020
Q3
$481K Buy
6,082
+2,618
+76% +$205K 0.48% 60
2020
Q2
$256K Buy
+3,464
New +$261K 0.26% 80
2019
Q2
Sell
-2,568
Closed -$205K 83
2019
Q1
$205K Buy
+2,568
New +$192K 0.19% 83

Other funds holding MRK

Providence Wealth Advisors's MRK Position: Q1 2026 in Review

Providence Wealth Advisors increased its Merck (MRK) stake by 1.8% in Q1 2026, buying an estimated $23K and bringing the position to 11,128 shares worth $1.35M. The position accounts for 0.86% of the portfolio, ranked #40.

Providence Wealth Advisors first reported a position in MRK in Q1 2019 and has held it in 25 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Providence Wealth Advisors held 11,128 shares of Merck worth $1.35M as of Q1 2026.
  • Providence Wealth Advisors bought 199 Merck shares in Q1 2026, an estimated $23K.
  • Merck made up 0.86% of Providence Wealth Advisors's portfolio in Q1 2026, its #40 holding.
  • Providence Wealth Advisors first reported a position in Merck in Q1 2019 and has held it in 25 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Providence Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.